Impact of an additional rupture of the residual membrane on labor timing
Official title: Impact of Early Rupture of the Residual Membrane on Latency Before Labour Begins
Run by Centre Hospitalier le Mans · NCT07301957 · Data updated 2026-11-12
This study tests whether intentionally rupturing the remaining membrane after it has already broken can change when labor starts in women who haven’t gone into labor on their own.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 130 (estimated) |
| Sponsor | Centre Hospitalier le Mans Academic / other |
| Locations | 2 sites (Angers and 1 other locations) |
| Status | Recruiting |
| Started | March 24, 2026 |
| Main results expected | March 24, 2028 |
| Study ends | March 24, 2028 |
| Registry record updated | July 1, 2026 |
| Trial ID | NCT07301957 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with a single pregnancy, cephalic presentation, ruptured membranes with a remaining intact membrane, and no spontaneous labor within 12 hours.
✕Probably not a fit
Patients whose labor timing is unaffected by the intervention or who experience complications from the procedure may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study explores whether a deliberate rupture of the residual membrane affects the latency to labor and the need for induction in women with prelabor rupture of membranes. Eligible participants are adults with a single pregnancy, cephalic presentation, and ruptured membranes but no spontaneous labor within 12 hours. The intervention involves an additional rupture of the residual membrane, with monitoring for labor onset and induction decisions at 24 or 48 hours depending on the center. The goal is to determine if this approach shortens latency to labor without increasing maternal or fetal infection risk. Prior literature on rupture of membranes has focused on frequency and timing of induction, with antibiotic prophylaxis reducing infection risk, and this study aims to address an unanswered question in this area.
Why it matters
Potential benefit: If successful, this approach could shorten the waiting period before labor begins and reduce the need for induction.
How similar studies have gone: There is limited prior research specifically addressing additional rupture of the residual membrane; results from pilot work suggested an effect but this remains relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women over 18 years of age * Single foetal pregnancy, cephalic presentation * diagnosis of membrane rupture with persistence of one membrane and absence of immediate spontaneous labour. * Person affiliated with or beneficiary of a social security scheme * Free, informed and written consent signed by the participant and the investigator (no later than the day of inclusion and before any examination required by the research). Exclusion Criteria: * Minor patient * patient under guardianship/curatorship, * multiple pregnancy, pregnancy with foetal death * non-cephalic presentation * gestational age less than 37 weeks, * rupture of membranes more than 12 hours ago * contraindication to vaginal deliver * meconium-stained amniotic fluid, * clinical signs suggestive of intrauterine infection (maternal hyperthermia \>38°C, maternal and/or foetal tachycardia, purulent amniotic fluid), * cervix not accessible for artificial rupture * vaginismus * contraindication to a potential expectant management * indication for induction for another reason
Where it's running
-
CHU Angers
Angers, France Recruiting -
Centre Hospitalier Le Mans
Le Mans, France Recruiting
Study contacts
- Principal investigator: Marie-Charlotte FAURANT, MD — Centre Hospitalier le Mans
- Study coordinator: Christelle JADEAU
- Email: recherchecliniquepromotion@ch-lemans.fr
- Phone: +33244710204
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Extended azithromycin treatment in prelabor rupture of membranes at periviable gestations
This study tests whether giving extra doses of azithromycin beyond the standard antibiotics can improve outcomes for pregnant people with PPROM between 22 and 28 weeks.
-
Predicting Adverse Pregnancy Outcomes in Uganda through Partnerships and Innovation
This study tests whether everyday health data, ultrasound, and blood samples from first-time pregnant women in Uganda can help predict problems like preeclampsia, fetal growth restriction, and preterm birth.
-
Using antibiotics to prolong pregnancy after premature rupture of membranes
This study is testing if giving antibiotics to women with a premature rupture of membranes can help them keep their pregnancy going longer.
-
Emotional Freedom Technique and Music Therapy in High-Risk Pregnancy for PPROM
This study tests whether emotional freedom techniques and music therapy can help pregnant women with PPROM or PROM cope better and feel less stress.
-
Tailored IL-6–guided antibiotic and steroid treatment to delay birth after PPROM
This tests whether using an IL-6 lab result from amniotic fluid to guide antibiotics and steroids can help people with PPROM stay pregnant longer and improve outcomes for parent and baby.
-
Papaverine given through IV to help with term PROM labor
This trial tests whether IV papaverine added to oxytocin helps shorten the time from infusion to delivery for women with term premature rupture of membranes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.